Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2010
11/04/2010US20100280073 Tricyclic inhibitors of hydroxysteroid dehydrogenases
11/04/2010US20100280072 2-'4-(hydroxymethyl-phenylamino) -piperidine-1-yl!-n- (9h-carbazol-3yl) - acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatment of obesity
11/04/2010US20100280067 Inhibitors of acetyl-coa carboxylase
11/04/2010US20100280060 Methods of screening and compositions for life span modulators
11/04/2010US20100280052 Use of antivirals to treat cmv-related conditions
11/04/2010US20100280049 Antagonists of pgd2 receptors
11/04/2010US20100280048 Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase
11/04/2010US20100280045 Novel compounds
11/04/2010US20100280041 Rhokinase-dependent inhibition activity on pulmonary artery endothelium dysfunction, medial wall thickness and vascular obstruction of pulmodil and pulmodil-1
11/04/2010US20100280035 Solid pharmaceutical composition comprising 1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine and a ph modifier
11/04/2010US20100280032 Method for treating inflammatory disorders
11/04/2010US20100280029 Novel compounds
11/04/2010US20100280028 Cxcr3 receptor antagonists
11/04/2010US20100280027 Pharmaceutical compounds
11/04/2010US20100280026 Compositions useful as inhibitors of protein kinases
11/04/2010US20100280025 Equilibrative nucleoside transporter ent1 inhibitors
11/04/2010US20100280024 Renin inhibitors
11/04/2010US20100280023 Thiazole derivatives
11/04/2010US20100280016 Pyrazoline compounds
11/04/2010US20100280015 Noval 1,4-diaza-biclo[3.2.2]nonyl oxadiazolyl derivatives useful as nicotinic acetylcholine receptor ligands
11/04/2010US20100280013 Carbinol derivatives having heterocyclic linker
11/04/2010US20100280007 Pyridazinone Derivatives
11/04/2010US20100280006 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling
11/04/2010US20100280005 Renin Inhibitors
11/04/2010US20100279994 Ansamycin Formulations and Methods of Use Thereof
11/04/2010US20100279986 Heterocyclic derived metalloprotease inhibitors
11/04/2010US20100279961 Pharmaceutical composition having a trihydroxy-chromenone derivative
11/04/2010US20100279960 Biotinylated hexadecasaccharides, preparation and use thereof
11/04/2010US20100279958 Compounds and methods for inhibiting selectin-mediated function
11/04/2010US20100279944 Suppression and treatment of neuropathic pain
11/04/2010US20100279941 Cd36 modulation and uses thereof
11/04/2010US20100279937 Method of Inhibiting Angiogenesis, Tumorigenesis and Cathepsin Activity
11/04/2010US20100279927 Growth factor complex
11/04/2010US20100279926 Compositions and Methods for Treating Atherosclerosis
11/04/2010US20100279923 Therapeutic application of kazal-type serine protease inhibitors
11/04/2010US20100279922 Melanocortin Receptor Ligands
11/04/2010US20100279406 Alteration of tumor growth using zinc finger proteins
11/04/2010US20100279333 Methods of treatment with antibodies to a chemokine expressed in inflamed adenoid
11/04/2010US20100279325 Use of modified extracellular matrix proteins in diagnosis and treatment of atherosclerosis
11/04/2010US20100278997 Preparation for restenosis prevention
11/04/2010US20100278942 Pharmaceutical composition comprising at least one thrombolytic agent (a) and at least one gas (b) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon
11/04/2010US20100278935 Immune System Modulator Formulation
11/04/2010US20100278933 Kinase inhibitor compounds
11/04/2010US20100278914 Fraction of melissa leaf extract having angiogenesis and mmp inhibitory activities, and composition comprising the same
11/04/2010US20100278909 Process for forming solid oral dosage forms of angiotensin ii receptor antagonists
11/04/2010US20100278907 Immunogenic Compositions Containing Ceramide and Methods of Use Thereof
11/04/2010US20100278901 Compositions and methods of making rapidly dissolving ionically masked formulations
11/04/2010US20100278899 Edible film
11/04/2010US20100278893 Implantable material comprising cellulose and the glycopeptide xyloglucan-grgds
11/04/2010US20100278887 Use of a Haemoglobin for the Preparation of Dressings and Resulting Dressings
11/04/2010US20100278879 Stable pharmaceutical composition and methods of using same
11/04/2010US20100278855 Neuroprotective ganoderma compositions and methods of use
11/04/2010US20100278838 Epha2 monoclonal antibodies and methods of use thereof
11/04/2010US20100278836 Diagnostic and therapeutic methods and compositions for cardiovascular disease
11/04/2010US20100278831 Nogo Receptor-Mediated Blockade of Axonal Growth
11/04/2010US20100278829 Dual inhibition of immunophilin/cyclophilin family members and emmprin immunoglobulin receptor superfamily members
11/04/2010US20100278811 Vasculostatic agents and methods of use thereof
11/04/2010US20100278810 Methods of Modulating Angiogenesis
11/04/2010US20100278809 Inhibitors of MRP4 for the Treatment of Vascular Disorders
11/04/2010US20100278805 Compositions for inhibiting atherosclerosis
11/04/2010US20100278787 Cardiomyocyte-like cell clusters derived from hbs cells
11/04/2010US20100278776 Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof
11/04/2010US20100278744 Preparation for restenosis prevention
11/04/2010US20100278738 Method to detect and monitor ischemia in transplanted organs and tissues
11/04/2010US20100278727 Alpha-Emitting constructs and uses thereof
11/04/2010US20100275431 Drug delivery from stents
11/04/2010CA2760387A1 Thiophene derivative
11/04/2010CA2760031A1 Acetone solvate crystals of trityl olmesartan medoxomil
11/04/2010CA2759883A1 Treatment or prophylaxis of proliferative conditions
11/04/2010CA2759859A1 Carbinol compound having heterocyclic linker
11/04/2010CA2759791A1 Novel therapeutic treatments using centhaquin
11/04/2010CA2759664A1 Bicarbonate solution for bioavailable magnesium and uses thereof
11/04/2010CA2759471A1 Heteroarylthiomethyl pyridine derivative
11/04/2010CA2759284A1 Stable pharmaceutical composition and methods of using same
11/04/2010CA2759163A1 Method for producing olmesartan medoxomil
11/04/2010CA2757761A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/03/2010EP2246430A1 Anti-adam-15 antibodies and utilization of the same
11/03/2010EP2246422A1 Polynucleotide or analogue thereof, and gene expression regulation method using the polynucleotide or the analogue thereof
11/03/2010EP2246360A1 Compositions for the treatment of gastrointestinal disorders
11/03/2010EP2246344A1 Pyrimidine compounds and medicinal composition thereof
11/03/2010EP2245030A1 Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and a pharmaceutical composition comprising it - 026
11/03/2010EP2245007A1 Novel crystalline forms
11/03/2010EP2244727A1 A method for restoring bmp-receptor signaling in a cell
11/03/2010EP2244725A1 Novel peptides and protein and uses thereof
11/03/2010EP2244710A1 A method of administering a pde3 inhibitor via titration for the treatment of peripheral arterial disease
11/03/2010EP2125827B1 Azaspiro derivatives
11/03/2010EP2066683B1 Derivatives of 5-thioxylopyranose and use of same for treatment
11/03/2010EP1863477B1 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
11/03/2010EP1702625B1 Medicine containing genetically modified antibody against chemokine receptor ccr4
11/03/2010EP1556080B1 Furin inhibitors for use in the treatment of fibrosis and scarring
11/03/2010EP1496838B1 Substituted amides
11/03/2010EP1490080B1 medical use of anthocyanins extracted from black rice
11/03/2010EP1469834B1 Multi-stage oral drug controlled-release system
11/03/2010EP1406615B1 Kinase inhibitors and the use thereof
11/03/2010EP1404302B1 Pharmaceutical compositions comprising adsorbates of amorphous drug
11/03/2010EP1296929B1 Modified forms of pharmacologically active agents and uses therefor
11/03/2010EP1292292B1 Method for treating congestive heart failure
11/03/2010EP1268760B1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments
11/03/2010EP1242437B1 Novel stromelysin inhibitors
11/03/2010EP1159457B1 T cell receptor vbeta - dbeta - jbeta) sequence and methods for its detection
1 ... 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 ... 1595